ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)
China
· Delayed Price · Currency is CNY 51.25
-0.42 (-0.81%)
Jun 5, 2025, 2:45 PM CST
SHE:300723 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 23,201 | 7,660 | 13,394 | 9,894 | 10,200 | 6,339 | Upgrade
|
| Market Cap Growth | 0.39% | -42.81% | 35.38% | -3.00% | 60.89% | 2.56% | Upgrade
|
| Enterprise Value | 24,945 | 8,774 | 13,988 | 10,650 | 10,763 | 6,181 | Upgrade
|
| Last Close Price | 51.67 | 17.06 | 29.55 | 22.74 | 23.45 | 14.51 | Upgrade
|
| PE Ratio | - | - | 72.55 | 34.04 | 33.23 | 28.10 | Upgrade
|
| Forward PE | 117.43 | 33.61 | 33.61 | 33.61 | 33.61 | 33.61 | Upgrade
|
| PS Ratio | 19.26 | 5.28 | 5.35 | 4.34 | 4.64 | 3.78 | Upgrade
|
| PB Ratio | 11.66 | 3.96 | 5.16 | 4.57 | 5.05 | 4.24 | Upgrade
|
| P/TBV Ratio | 15.33 | 5.28 | 6.49 | 6.27 | 7.27 | 5.34 | Upgrade
|
| P/FCF Ratio | - | - | 108.38 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 29.24 | 20.81 | 23.28 | 23.03 | Upgrade
|
| EV/Sales Ratio | 20.71 | 6.05 | 5.59 | 4.67 | 4.89 | 3.69 | Upgrade
|
| EV/EBITDA Ratio | - | - | 36.11 | 29.06 | 35.20 | 27.47 | Upgrade
|
| EV/EBIT Ratio | - | - | 60.99 | 36.15 | 42.00 | 33.52 | Upgrade
|
| EV/FCF Ratio | -30.47 | - | 113.18 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.26 | 0.87 | 0.31 | 0.54 | 0.61 | 0.19 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 1.95 | 2.98 | 3.73 | 1.29 | Upgrade
|
| Debt / FCF Ratio | - | - | 6.49 | - | - | - | Upgrade
|
| Asset Turnover | 0.24 | 0.33 | 0.59 | 0.58 | 0.75 | 0.85 | Upgrade
|
| Inventory Turnover | 1.98 | 1.82 | 1.84 | 2.05 | 2.86 | 3.11 | Upgrade
|
| Quick Ratio | 0.71 | 0.48 | 0.62 | 0.93 | 1.13 | 1.85 | Upgrade
|
| Current Ratio | 1.13 | 0.73 | 0.91 | 1.17 | 1.30 | 2.17 | Upgrade
|
| Return on Equity (ROE) | -26.00% | -25.00% | 6.37% | 12.53% | 16.70% | 15.77% | Upgrade
|
| Return on Assets (ROA) | -5.34% | -4.16% | 3.37% | 4.71% | 5.45% | 5.85% | Upgrade
|
| Return on Capital (ROIC) | -6.32% | -5.22% | 4.26% | 5.59% | 6.37% | 6.93% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 7.90% | 10.20% | 10.20% | 11.60% | Upgrade
|
| Earnings Yield | -2.52% | -7.05% | 1.38% | 2.94% | 3.01% | 3.56% | Upgrade
|
| FCF Yield | -3.53% | -11.36% | 0.92% | -1.32% | -1.21% | -0.61% | Upgrade
|
| Dividend Yield | 0.41% | - | 0.71% | 0.59% | 0.57% | 0.64% | Upgrade
|
| Payout Ratio | - | - | 35.77% | 21.88% | 12.90% | 16.33% | Upgrade
|
| Buyback Yield / Dilution | -0.13% | 0.00% | -4.43% | -1.94% | 2.20% | -0.64% | Upgrade
|
| Total Shareholder Return | 0.28% | 0.00% | -3.72% | -1.35% | 2.77% | -0.00% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.